vs

Side-by-side financial comparison of Axon Enterprise (AXON) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $796.7M, roughly 1.7× Axon Enterprise). PACS Group, Inc. runs the higher net margin — 4.4% vs 0.3%, a 4.1% gap on every dollar of revenue. On growth, Axon Enterprise posted the faster year-over-year revenue change (38.9% vs 18.4%). Over the past eight quarters, Axon Enterprise's revenue compounded faster (31.5% CAGR vs 20.5%).

Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians.

AXON vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.7× larger
PACS
$1.4B
$796.7M
AXON
Growing faster (revenue YoY)
AXON
AXON
+20.5% gap
AXON
38.9%
18.4%
PACS
Higher net margin
PACS
PACS
4.1% more per $
PACS
4.4%
0.3%
AXON
Faster 2-yr revenue CAGR
AXON
AXON
Annualised
AXON
31.5%
20.5%
PACS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AXON
AXON
PACS
PACS
Revenue
$796.7M
$1.4B
Net Profit
$2.7M
$59.7M
Gross Margin
57.9%
Operating Margin
-6.3%
7.0%
Net Margin
0.3%
4.4%
Revenue YoY
38.9%
18.4%
Net Profit YoY
-98.0%
3022.5%
EPS (diluted)
$0.02
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXON
AXON
PACS
PACS
Q4 25
$796.7M
$1.4B
Q3 25
$710.6M
$1.3B
Q2 25
$668.5M
$1.3B
Q1 25
$603.6M
$1.3B
Q4 24
$573.4M
$1.1B
Q3 24
$544.3M
$1.0B
Q2 24
$504.1M
$981.4M
Q1 24
$460.7M
$934.3M
Net Profit
AXON
AXON
PACS
PACS
Q4 25
$2.7M
$59.7M
Q3 25
$-2.2M
$52.4M
Q2 25
$36.1M
$51.0M
Q1 25
$88.0M
$28.5M
Q4 24
$136.0M
$1.9M
Q3 24
$67.0M
$15.6M
Q2 24
$40.8M
$-10.9M
Q1 24
$133.2M
$49.1M
Gross Margin
AXON
AXON
PACS
PACS
Q4 25
57.9%
Q3 25
60.1%
Q2 25
60.4%
Q1 25
60.6%
Q4 24
60.5%
Q3 24
60.8%
17.1%
Q2 24
60.3%
22.3%
Q1 24
56.4%
21.2%
Operating Margin
AXON
AXON
PACS
PACS
Q4 25
-6.3%
7.0%
Q3 25
-0.3%
6.4%
Q2 25
-0.2%
6.2%
Q1 25
-1.5%
3.8%
Q4 24
-2.6%
1.7%
Q3 24
4.4%
2.2%
Q2 24
6.5%
0.1%
Q1 24
3.5%
8.6%
Net Margin
AXON
AXON
PACS
PACS
Q4 25
0.3%
4.4%
Q3 25
-0.3%
3.9%
Q2 25
5.4%
3.9%
Q1 25
14.6%
2.2%
Q4 24
23.7%
0.2%
Q3 24
12.3%
1.5%
Q2 24
8.1%
-1.1%
Q1 24
28.9%
5.3%
EPS (diluted)
AXON
AXON
PACS
PACS
Q4 25
$0.02
$0.42
Q3 25
$-0.03
$0.32
Q2 25
$0.44
$0.31
Q1 25
$1.08
$0.17
Q4 24
$1.68
$-0.03
Q3 24
$0.86
$0.10
Q2 24
$0.53
$-0.07
Q1 24
$1.73
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXON
AXON
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$1.7B
$197.0M
Total DebtLower is stronger
$1.8B
$353.2M
Stockholders' EquityBook value
$3.2B
$946.8M
Total Assets
$7.0B
$5.6B
Debt / EquityLower = less leverage
0.56×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXON
AXON
PACS
PACS
Q4 25
$1.7B
$197.0M
Q3 25
$2.4B
$355.7M
Q2 25
$2.1B
$294.2M
Q1 25
$2.2B
$287.5M
Q4 24
$788.1M
$157.7M
Q3 24
$1.0B
$49.5M
Q2 24
$968.9M
$73.4M
Q1 24
$964.1M
$81.2M
Total Debt
AXON
AXON
PACS
PACS
Q4 25
$1.8B
$353.2M
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$680.3M
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AXON
AXON
PACS
PACS
Q4 25
$3.2B
$946.8M
Q3 25
$3.0B
$871.3M
Q2 25
$2.7B
$806.8M
Q1 25
$2.6B
$750.2M
Q4 24
$2.3B
$709.6M
Q3 24
$2.1B
$660.0M
Q2 24
$1.9B
$572.1M
Q1 24
$1.8B
$128.0M
Total Assets
AXON
AXON
PACS
PACS
Q4 25
$7.0B
$5.6B
Q3 25
$6.7B
$5.6B
Q2 25
$6.2B
$5.5B
Q1 25
$6.1B
$5.5B
Q4 24
$4.5B
$5.2B
Q3 24
$4.0B
$4.5B
Q2 24
$3.7B
$3.9B
Q1 24
$3.6B
$3.9B
Debt / Equity
AXON
AXON
PACS
PACS
Q4 25
0.56×
0.37×
Q3 25
0.66×
Q2 25
0.73×
Q1 25
0.79×
Q4 24
0.29×
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXON
AXON
PACS
PACS
Operating Cash FlowLast quarter
$217.2M
$-3.4M
Free Cash FlowOCF − Capex
$155.4M
FCF MarginFCF / Revenue
19.5%
Capex IntensityCapex / Revenue
7.8%
Cash ConversionOCF / Net Profit
79.14×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$75.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXON
AXON
PACS
PACS
Q4 25
$217.2M
$-3.4M
Q3 25
$60.0M
$204.8M
Q2 25
$-91.7M
$52.6M
Q1 25
$25.8M
$150.2M
Q4 24
$250.2M
$64.6M
Q3 24
$91.3M
$209.2M
Q2 24
$82.8M
$34.8M
Q1 24
$-15.9M
$58.8M
Free Cash Flow
AXON
AXON
PACS
PACS
Q4 25
$155.4M
Q3 25
$33.4M
Q2 25
$-114.7M
Q1 25
$932.0K
Q4 24
$225.4M
Q3 24
$64.8M
Q2 24
$71.4M
Q1 24
$-32.1M
FCF Margin
AXON
AXON
PACS
PACS
Q4 25
19.5%
Q3 25
4.7%
Q2 25
-17.2%
Q1 25
0.2%
Q4 24
39.3%
Q3 24
11.9%
Q2 24
14.2%
Q1 24
-7.0%
Capex Intensity
AXON
AXON
PACS
PACS
Q4 25
7.8%
Q3 25
3.7%
Q2 25
3.4%
Q1 25
4.1%
Q4 24
4.3%
Q3 24
4.9%
Q2 24
2.2%
Q1 24
3.5%
Cash Conversion
AXON
AXON
PACS
PACS
Q4 25
79.14×
-0.06×
Q3 25
3.91×
Q2 25
-2.54×
1.03×
Q1 25
0.29×
5.28×
Q4 24
1.84×
33.78×
Q3 24
1.36×
13.39×
Q2 24
2.03×
Q1 24
-0.12×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXON
AXON

Software And Sensors Segment$342.5M43%
TASER Devices Professional$264.2M33%
Personal Sensors$109.1M14%
Platform Solutions$80.9M10%

PACS
PACS

Segment breakdown not available.

Related Comparisons